SEC Form 4 · accession 0001140361-16-056639
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Enxing
Officer — VP of Sales & Marketing
Period of report
Mar 3, 2016
Accepted (ET)
Mar 7, 2016 · 11:43 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 3, 2016 | M | 37,000 | $3.60 | A | 37,413 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $3.60 | Mar 3, 2016 | M | 37,000 | D | — | Dec 17, 2022 | Common Stock | 37,000 | 100,875 | D |
Explanation of responses
- F1Includes 413 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 13, 2015.
- F225% of the shares subject to the option vest on the first anniversary measured from December 1, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.